Early Screen and Treatment for Gestational Diabetes
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - 45 |
| Updated: | 4/21/2016 |
| Start Date: | March 2015 |
| End Date: | February 2017 |
| Contact: | Alejandro R Rodriguez, MD |
| Email: | arodri24@health.usf.edu |
| Phone: | 813-259-0828 |
Gestational Diabetes Mellitus: Does Early Screening and Treatment for Patients at Increased Risk for Gestational Diabetes Impact Perinatal Outcomes? A Randomized Controlled Trial
In the current study we aim to determine if early glucose screening and treatment among
women at high risk for GDM improves perinatal outcome and decreases gestational weight gain.
Half of the participant will be assigned to an early glucose screen group (12-18 weeks) and
treatment if necessary and the other half to a standard 24-28 weeks glucose screen.
women at high risk for GDM improves perinatal outcome and decreases gestational weight gain.
Half of the participant will be assigned to an early glucose screen group (12-18 weeks) and
treatment if necessary and the other half to a standard 24-28 weeks glucose screen.
Inclusion Criteria:
Pregnant subjects 18-45 y/o and Any of the following:
Obesity defined as having a BMI>30 kg/m2 History of pregnancy complicated with GDM History
of pregnancy complicated with macrosomia First degree relative with diabetes Multiple
gestation
Exclusion Criteria:
- Incomplete Data: if any data is missing (i.e Delivery data) , analysis cannot be
completed.
Pregnancy complicated with fetal malformations or aneuploidy: It affects prenatal care,
mode of delivery as well as perinatal outcome.
Pregestational or Overt Diabetes: Patients with Diabetes cannot be diagnosed with GDM.
Chronic medical conditions such as hypertension, renal disease, autoimmune conditions:
Those conditions may affect prenatal care, perinatal morbidity.
Early diabetes screen performed prior to enrollment in study: Participant cannot be
randomized, and probably have been treated.
Medical contraindication to glucose tolerance test (bariatric surgery): patients with h/o
gastric bypass frequently cannot tolerate oral glucose load, therefore cannot be screened
for GDM in the traditional way.
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials